As of 2026-03-24, the Relative Valuation of Altimmune Inc (ALT) is (16.98) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.44 USD, the upside of Altimmune Inc based on Relative Valuation is -593.6%.
The range of the Relative Valuation is (16.01) - (17.18) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 20.0x - 24.5x | 22.2x |
| Forward P/E multiples | 20.5x - 22.0x | 21.2x |
| Fair Price | (16.01) - (17.18) | (16.98) |
| Upside | -565.3% - -599.3% | -593.6% |
| Date | P/E |
| 2026-03-13 | -4.48 |
| 2026-03-12 | -4.61 |
| 2026-03-11 | -4.87 |
| 2026-03-10 | -4.94 |
| 2026-03-09 | -4.97 |
| 2026-03-06 | -4.53 |
| 2026-03-05 | -4.49 |
| 2026-03-04 | -5.47 |
| 2026-03-03 | -5.33 |
| 2026-03-02 | -5.33 |
| 2026-02-27 | -5.52 |
| 2026-02-26 | -5.71 |
| 2026-02-25 | -5.84 |
| 2026-02-24 | -5.85 |
| 2026-02-23 | -5.79 |
| 2026-02-20 | -5.61 |
| 2026-02-19 | -5.75 |
| 2026-02-18 | -5.71 |
| 2026-02-17 | -5.76 |
| 2026-02-13 | -5.80 |
| 2026-02-12 | -5.85 |
| 2026-02-11 | -5.93 |
| 2026-02-10 | -5.96 |
| 2026-02-09 | -6.01 |
| 2026-02-06 | -6.24 |
| 2026-02-05 | -6.30 |
| 2026-02-04 | -6.57 |
| 2026-02-03 | -7.01 |
| 2026-02-02 | -7.11 |
| 2026-01-30 | -7.17 |
| 2026-01-29 | -6.53 |
| 2026-01-28 | -6.56 |
| 2026-01-27 | -7.92 |
| 2026-01-26 | -7.25 |
| 2026-01-23 | -7.04 |
| 2026-01-22 | -6.89 |
| 2026-01-21 | -5.92 |
| 2026-01-20 | -5.42 |
| 2026-01-16 | -5.43 |
| 2026-01-15 | -5.43 |
| 2026-01-14 | -5.35 |
| 2026-01-13 | -5.14 |
| 2026-01-12 | -5.19 |
| 2026-01-09 | -5.15 |
| 2026-01-08 | -5.23 |
| 2026-01-07 | -5.37 |
| 2026-01-06 | -5.07 |
| 2026-01-05 | -5.24 |
| 2026-01-02 | -4.50 |
| 2025-12-31 | -4.62 |